POPULATION PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA FOLLOWING SUBCUTANEOUS INFUSION

被引：0
|
作者：
Birnberg, T. [1 ]
Adar, L. [1 ]
Smania, G. [2 ]
Bjornsson, M. [2 ]
Jonsson, N. [2 ]
Case, R. [2 ]
Karlsson, M. O. [3 ]
机构：
[1] NeuroDerm, Rehovot, Israel
[2] Pharmetheus, Uppsala, Sweden
[3] Uppsala Univ, Uppsala, Sweden
来源：
PARKINSONISM & RELATED DISORDERS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P 121
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model
    Birnberg, T.
    Adar, L.
    Perlstein, I.
    Smania, G.
    Bjornsson, M.
    Jonnson, N.
    Karlsson, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 235 - 235
  • [2] Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model
    Birnberg, Tal
    Smania, Giovanni
    Bjornsson, Marcus
    Jonsson, Niclas
    Case, Ryan
    Oren, Sheila
    Adar, Liat
    Karlsson, Mats
    NEUROLOGY, 2021, 96 (15)
  • [3] Pharmacokinetics-pharmacodynamics of levodopa/carbidopa following subcutaneous infusion with ND0612
    Birnberg, T.
    Adar, L.
    Poewe, W.
    Nyholm, D.
    Bjornsson, M.
    Karlsson, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 608 - 608
  • [4] Administration of continuous subcutaneous carbidopa improves levodopa pharmacokinetics
    Yacoby-Zeevi, O.
    Oren, S.
    LeWitt, P.
    MOVEMENT DISORDERS, 2011, 26 : S284 - S284
  • [5] Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion
    Rosebraugh, Matthew
    Liu, Wei
    Neenan, Melina
    Facheris, Maurizio F.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (04) : 1695 - 1702
  • [6] The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
    LeWitt, Peter A.
    Stocchi, Fabrizio
    Arkadir, David
    Caraco, Yoseph
    Adar, Liat
    Perlstein, Itay
    Case, Ryan
    Giladi, Nir
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [7] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
    Moes, Harmen R.
    Buskens, Erik
    van Laar, Teus
    LANCET NEUROLOGY, 2024, 23 (09): : 856 - 857
  • [8] Markedly enhanced levodopa pharmacokinetics from continuous subcutaneous carbidopa administration
    Yacoby-Zeevi, O.
    Oren, S.
    LeWitt, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 52 - 52
  • [9] Continuous Administration of Subcutaneous Levodopa/Carbidopa (ND0612) Demonstrated Comparable Levodopa Pharmacokinetics to Levodopa/Carbidopa Intestinal Gel (LCIG)
    Adar, Liat
    Minei, Tamar Rachmilewitz
    Cohen, Yael
    Oren, Sheila
    NEUROLOGY, 2017, 88
  • [10] PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION
    BREDBERG, E
    LENNERNAS, H
    PAALZOW, L
    PHARMACEUTICAL RESEARCH, 1994, 11 (04) : 549 - 555
12345